Gwo Xi Stem Cell Applied Technology Co., Ltd.(TW:6704)
NT$20.20+0.05 (+0.25%)
TW:6704
Gwo Xi Stem Cell Applied Technology Co., Ltd. financials statements
NT$20.20
At close:+0.05 (+0.25%)
Gwo Xi Stem Cell Applied Technology Co., Ltd. (6704) Ratios
Gwo Xi Stem Cell Applied Technology Co., Ltd. Ratios
TW:6704's free cash flow for Q2 2026 was NT$-40.86M. For the 2026 fiscal year, TW:6704's free cash flow was decreased by NT$-3.99M and operating cash flow was NT$-36.87M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.98 | 3.94 | 3.67 | 1.88 | 1.31 |
| Quick Ratio | 1.88 | 3.81 | 3.57 | 1.76 | 1.07 |
| Cash Ratio | 1.68 | 2.97 | 2.97 | 1.32 | 0.86 |
| Solvency Ratio | -0.06 | -0.06 | -0.06 | -0.10 | -0.12 |
| Operating Cash Flow Ratio | -0.24 | -0.67 | -0.04 | -0.60 | -0.21 |
| Short-Term Operating Cash Flow Coverage | -0.36 | -1.42 | -0.11 | -0.97 | -0.37 |
| Net Current Asset Value | NT$ -170.43M | NT$ -91.67M | NT$ -57.13M | NT$ -333.79M | NT$ -415.15M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.37 | 0.34 | 0.34 | 0.48 | 0.50 |
| Debt-to-Equity Ratio | 0.63 | 0.55 | 0.56 | 0.98 | 1.13 |
| Debt-to-Capital Ratio | 0.39 | 0.36 | 0.36 | 0.49 | 0.53 |
| Long-Term Debt-to-Capital Ratio | 0.30 | 0.30 | 0.30 | 0.42 | 0.45 |
| Financial Leverage Ratio | 1.69 | 1.61 | 1.65 | 2.05 | 2.25 |
| Debt Service Coverage Ratio | -0.17 | -0.29 | -0.30 | -0.75 | -0.82 |
| Interest Coverage Ratio | -7.49 | -6.64 | -7.60 | -58.88 | -59.43 |
| Debt to Market Cap | 0.12 | 0.12 | 0.11 | 0.11 | 0.13 |
| Interest Debt Per Share | 3.91 | 3.92 | 4.79 | 5.87 | 6.59 |
| Net Debt to EBITDA | -11.37 | -9.50 | -4.46 | -7.17 | -7.04 |
| Profitability Margins | |||||
| Gross Profit Margin | 39.30% | 68.60% | 68.55% | 85.69% | 81.18% |
| EBIT Margin | -39.39% | -42.28% | -52.98% | -60.32% | -39.24% |
| EBITDA Margin | -8.13% | -8.12% | -11.76% | -27.64% | -24.93% |
| Operating Profit Margin | -39.39% | -44.66% | -66.55% | -63.81% | -40.96% |
| Pretax Profit Margin | -43.05% | -49.00% | -61.73% | -61.40% | -39.93% |
| Net Profit Margin | -43.05% | -49.00% | -62.40% | -62.05% | -43.48% |
| Continuous Operations Profit Margin | -43.05% | -49.00% | -62.40% | -61.78% | -42.32% |
| Net Income Per EBT | 100.00% | 100.02% | 101.08% | 101.06% | 108.89% |
| EBT Per EBIT | 109.30% | 109.71% | 92.76% | 96.22% | 97.50% |
| Return on Assets (ROA) | -8.23% | -7.85% | -7.19% | -10.73% | -9.70% |
| Return on Equity (ROE) | -13.87% | -12.61% | -11.84% | -21.97% | -21.88% |
| Return on Capital Employed (ROCE) | -8.53% | -7.72% | -8.46% | -12.29% | -10.46% |
| Return on Invested Capital (ROIC) | -7.79% | -7.41% | -8.09% | -11.42% | -9.59% |
| Return on Tangible Assets | -9.85% | -9.25% | -8.28% | -12.72% | -11.46% |
| Earnings Yield | -3.11% | -3.14% | -2.75% | -2.85% | -2.76% |
| Efficiency Ratios | |||||
| Receivables Turnover | 14.76 | 12.88 | 22.66 | 9.35 | 12.33 |
| Payables Turnover | 15.11 | 8.84 | 13.45 | 4.46 | 861.96 |
| Inventory Turnover | 10.24 | 5.46 | 3.62 | 1.93 | 1.37 |
| Fixed Asset Turnover | 0.32 | 0.29 | 0.22 | 0.27 | 0.33 |
| Asset Turnover | 0.19 | 0.16 | 0.12 | 0.17 | 0.22 |
| Working Capital Turnover Ratio | 1.09 | 0.63 | 0.70 | 2.64 | 2.30 |
| Cash Conversion Cycle | 36.21 | 53.90 | 89.88 | 146.83 | 295.42 |
| Days of Sales Outstanding | 24.73 | 28.34 | 16.11 | 39.02 | 29.61 |
| Days of Inventory Outstanding | 35.63 | 66.86 | 100.90 | 189.61 | 266.23 |
| Days of Payables Outstanding | 24.15 | 41.30 | 27.14 | 81.80 | 0.42 |
| Operating Cycle | 60.36 | 95.20 | 117.01 | 228.63 | 295.84 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.29 | -0.54 | -0.05 | -0.75 | -0.35 |
| Free Cash Flow Per Share | -0.84 | -0.78 | -0.20 | -0.96 | -0.87 |
| Dividend Paid and CapEx Coverage Ratio | -0.53 | -2.27 | -0.38 | -3.63 | -0.67 |
| Capital Expenditure Coverage Ratio | -0.53 | -2.27 | -0.38 | -3.63 | -0.67 |
| Operating Cash Flow Coverage Ratio | -0.08 | -0.14 | -0.01 | -0.13 | -0.05 |
| Operating Cash Flow to Sales Ratio | -0.15 | -0.31 | -0.03 | -0.36 | -0.12 |
| Free Cash Flow Yield | -3.12% | -2.84% | -0.56% | -2.08% | -1.89% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -32.14 | -31.78 | -36.48 | -35.15 | -36.26 |
| Price-to-Sales (P/S) Ratio | 13.85 | 15.60 | 22.68 | 21.77 | 15.73 |
| Price-to-Book (P/B) Ratio | 4.46 | 4.01 | 4.30 | 7.71 | 7.92 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -32.09 | -35.23 | -180.06 | -48.04 | -52.79 |
| Price-to-Operating Cash Flow Ratio | -92.58 | -50.74 | -657.02 | -61.28 | -131.13 |
| Price-to-Earnings Growth (PEG) Ratio | 9.32 | 2.83 | 1.45 | -11.16 | -1.12 |
| Enterprise Value Multiple | -181.81 | -201.61 | -197.39 | -85.95 | -70.13 |
| Enterprise Value | 2.76B | 2.78B | 3.28B | 4.29B | 4.24B |
| EV to EBITDA | -181.81 | -201.61 | -197.39 | -85.95 | -70.13 |
| EV to Sales | 14.78 | 16.37 | 23.21 | 23.75 | 17.49 |
| EV to Free Cash Flow | -34.23 | -36.98 | -184.22 | -52.41 | -58.67 |
| EV to Operating Cash Flow | -98.75 | -53.25 | -672.21 | -66.86 | -145.76 |
| Tangible Book Value Per Share | 4.38 | 5.21 | 6.50 | 4.06 | 3.93 |
| Shareholders’ Equity Per Share | 6.05 | 6.89 | 8.31 | 5.97 | 5.82 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | -0.00 | -0.01 | -0.01 | -0.06 |
| Revenue Per Share | 1.95 | 1.77 | 1.58 | 2.12 | 2.93 |
| Net Income Per Share | -0.84 | -0.87 | -0.98 | -1.31 | -1.27 |
| Tax Burden | 1.00 | 1.00 | 1.01 | 1.01 | 1.09 |
| Interest Burden | 1.09 | 1.16 | 1.17 | 1.02 | 1.02 |
| Research & Development to Revenue | 0.62 | 0.65 | 0.77 | 0.60 | 0.39 |
| SG&A to Revenue | 0.17 | 0.48 | 0.59 | 0.89 | 0.84 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.35 | 0.63 | 0.06 | 0.57 | 0.27 |
Currency in TWD
